Human iPS cell line. HPS0002, HPS0063, HPS0076, HPS0296, HPS0326, HPS3668, HPS4290, HPS4291, HPS4292 are derived from the same person. Order Form (C-0042, C-0007 or C-0007p). Yamanaka, Shinya ヒト人工多能性幹(iPS)細胞株。HPS0002, HPS0063, HPS0076, HPS0296, HPS0326, HPS3668, HPS4290, HPS4291, HPS4292は同一人由来。エピソーマルベクター (pCXLE)によりヒト6因子（Oct3/4,Sox2,Klf4,L-Myc,Lin28,p53 shRNA）導入。導入遺伝子は残っていない。<a href='http://cell.brc.riken.jp/ja/manual/vitrification' target="_blank">ガラス化法（Vitrification法）</a>保存。 1) 非営利機関以外の利用者は事前に<a href= 'http://ips-cell.net/j/index.php' target="_blank">iPSアカデミアジャパン株式会社 </a>から確認書を得ること。2) <a href='http://cell.brc.riken.jp/ja/wp-content/uploads/restriction/HPS0002,HPS0063,HPS0076_non-for-profit.pdf' target="_blank">別紙1 (非営利) </a>または<a href='http://cell.brc.riken.jp/ja/wp-content/uploads/restriction/HPS0002,HPS0063,HPS0076_for-profit.pdf' target="_blank">別紙1 (営利) </a>を提供同意書 (C-0003またはC-0003p) に添付すること。 HPS0076 409B2 ヒト人工多能性幹(iPS)細胞株。HPS0002, HPS0063, HPS0076, HPS0296, HPS0326, HPS3668, HPS4290, HPS4291, HPS4292は同一人由来。エピソーマルベクター (pCXLE)によりヒト6因子（Oct3/4,Sox2,Klf4,L-Myc,Lin28,p53 shRNA）導入。導入遺伝子は残っていない。<a href='https://cell.brc.riken.jp/ja/manual/vitrification' target="_blank">ガラス化法（Vitrification法）</a>保存。 Human iPS cell line. HPS0002, HPS0063, HPS0076, HPS0296, HPS0326, HPS3668, HPS4290, HPS4291, HPS4292 are derived from the same person. <a href="http://www.cira.kyoto-u.ac.jp/" target="_blank">http://www.cira.kyoto-u.ac.jp/</a> 1) In relation to the for-profit organizations, please contact <a href= 'http://ips-cell.net/e/index.php' target="_blank">iPS Academia Japan, Inc.</a>, prior to the utilization of iPS cells. 2) Attach <a href='http://cell.brc.riken.jp/en/wp-content/uploads/restriction/HPS0002,HPS0063,HPS0076_non-for-profit_en.pdf' target="_blank">TERMS and CONDITIONS (non-for-profit) </a> or <a href='http://cell.brc.riken.jp/en/wp-content/uploads/restriction/HPS0002,HPS0063,HPS0076_for-profit_en.pdf' target="_blank">TERMS and CONDITIONS (for-profit) </a> to MTA (C-0007 or C-0007p) .